China Shineway Pharmaceutical Group Limited (HK:2877) has released an update.
Despite a 13% decline in overall sales for the first half of 2024, China Shineway Pharmaceutical Group Limited reported a 27.5% surge in net profit to RMB626,479,000, with earnings per share up by 27.7%. This financial boost is attributed to increased income, cost control measures, and enhanced efficiency leading to a higher net profit margin. Additionally, the company announced a second interim dividend of RMB11 cents per share, contributing to a total of RMB54 cents per share in dividends over the past twelve months.
For further insights into HK:2877 stock, check out TipRanks’ Stock Analysis page.